NVIDIA BioNeMo Wins Lilly, Thermo Fisher as AI Drug Discovery Shifts to Production Scale
NVIDIA's BioNeMo platform has secured partnerships with Eli Lilly and Thermo Fisher as pharmaceutical companies establish co-innovation labs for AI-driven drug discovery. Multiple biotech AI platforms including Natera, Basecamp Research, Owkin, and Edison Scientific simultaneously launched foundation models, signaling the sector's transition from experimental pilots to industrial-scale AI integration.
Salvado•